Biologics and Downstream Processing in the Pharmaceutical Solvent Market
While the historical narrative of the pharmaceutical industry was dominated by chemically synthesized small molecules (pills and capsules), the modern era of medicine belongs unequivocally to biologics. Large-molecule therapeutics—such as monoclonal antibodies, recombinant proteins, and advanced gene therapies—are fundamentally rewriting the rules of clinical oncology and autoimmune...
0 Комментарии 0 Поделились 376 Просмотры 0 предпросмотр
SocioMint https://sociomint.com